Bayforest Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
1,268
-3,546
-74% -$317K 0.12% 326
2026
Q1
$346K Buy
4,814
+3,938
+450% +$303K 0.39% 17
2025
Q4
$69.5K Sell
876
-552
-39% -$43.5K 0.05% 536
2025
Q3
$108K Buy
1,428
+1,113
+353% +$76.3K 0.05% 513
2025
Q2
$21.7K Sell
315
-4,566
-94% -$299K 0.01% 579
2025
Q1
$331K Buy
+4,881
New +$292K 0.14% 272

Other funds holding CVS

Bayforest Capital's CVS Position: Q2 2026 in Review

Bayforest Capital reduced its CVS Health (CVS) stake by 74% in Q2 2026, selling an estimated $317K and leaving 1,268 shares worth $131K. The position accounts for 0.12% of the portfolio, ranked #326.

Bayforest Capital first reported a position in CVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $346K in Q1 2026. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bayforest Capital held 1,268 shares of CVS Health worth $131K as of Q2 2026.
  • Bayforest Capital sold 3,546 CVS Health shares in Q2 2026, an estimated $317K.
  • CVS Health made up 0.12% of Bayforest Capital's portfolio in Q2 2026, its #326 holding.
  • Bayforest Capital first reported a position in CVS Health in Q1 2025 and has held it in 6 quarters since.
  • Bayforest Capital's CVS Health position peaked at $346K in Q1 2026.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.